BNTC insider buying – Benitec Biopharma Inc.
9 insider purchases since 2016 worth $37.2M by 5 different insiders. Last 12 months: 3 purchases, $22.4M. Most recent filing: 2025-12-29.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 1 older purchase (before the 5-year window) is listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | $20.6M 3× · 1,539,978 sh | 2024-12-03 2025-11-07 | – | 9,538,175 shares as of 2025-11-10 | Holds - never sold |
| Cowen Aaron Director | $14.1M 3× · 1,091,743 sh | 2024-12-23 2025-12-23 | – | 1,848,156 shares as of 2025-12-29 | Holds - never sold |
| Oliveira Steven Michael 10% Owner | $1.5M 1× · 331,877 sh | 2021-04-28 2021-04-28 | – | 911,000 shares as of 2021-12-09 | Holds - never sold |
| Averill Madison Master Fund, Ltd. Director | $538,972 1× · 46,141 sh | 2025-12-18 2025-12-18 | – | 1,826,653 shares as of 2025-12-22 | Holds - never sold |
| Averill Master Fund, Ltd. Director | $416,616 1× · 41,436 sh | 2024-11-19 2024-11-19 | – | 7,895,815 shares as of 2024-11-21 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2025 | 5 | $34.4M | 3 | – | – |
| 2024 | 3 | $1.3M | 3 | – | – |
| 2021 | 1 | $1.5M | 1 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-12-29 | Cowen Aaron | Director | 144,223 | $13.20 | $1.9M | +1.5% | SEC |
| 2025-12-22 | Averill Madison Master Fund, Ltd. | Director | 46,141 | $11.68 | $538,972 | +0.5% | SEC |
| 2025-11-10 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | 1,481,481 | $13.50 | $20.0M | +18.4% | SEC |
| 2025-04-02 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | 16,497 | $12.83 | $211,736 | +0.2% | SEC |
| 2025-03-28 | Cowen Aaron | Director | 900,000 | $13.00 | $11.7M | +11.4% | SEC |
| 2024-12-26 | Cowen Aaron | Director | 47,520 | $11.09 | $527,174 | +0.6% | SEC |
| 2024-12-05 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | 42,000 | $9.60 | $403,200 | +0.5% | SEC |
| 2024-11-21 | Averill Master Fund, Ltd. | Director | 41,436 | $10.05 | $416,616 | +0.5% | SEC |
| 2021-12-09 | Oliveira Steven Michael | 10% Owner | 331,877 | $4.51 | $1.5M | +49.7% | SEC |
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free